Trial Profile
An International, Multi-centre, Randomised, Stratified, Double-blinded, Placebo-controlled, 4-parallel Group Trial Investigating the Efficacy and Safety of Three Different Dose Levels of CRD007 (The AORTA Trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2015
Price :
$35
*
At a glance
- Drugs Pemirolast (Primary)
- Indications Abdominal aortic aneurysm
- Focus Therapeutic Use
- Acronyms The AORTA Trial
- Sponsors Cardoz
- 01 Jul 2015 Results published in the British Journal of Surgery.
- 22 Apr 2014 New trial record